scispace - formally typeset
S

Seitaro Nomura

Researcher at University of Tokyo

Publications -  60
Citations -  1516

Seitaro Nomura is an academic researcher from University of Tokyo. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 42 publications receiving 827 citations. Previous affiliations of Seitaro Nomura include Jichi Medical University.

Papers
More filters
Journal ArticleDOI

Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure

TL;DR: It is suggested that patients with HF harbor significantly altered gut microbiota, which varies further according to age, and new concept of heart-gut axis has a great potential for breakthroughs in the development of novel diagnostic and therapeutic approach for HF.
Journal ArticleDOI

Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure

TL;DR: The authors identify the gene programs encoding the morphological and functional characteristics of cardiomyocytes during the transition from early hypertrophy to heart failure via single-cell transcriptomics, establishing a key role for p53 signalling.
Journal ArticleDOI

Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.

TL;DR: A large-scale genome-wide association study of 168,228 individuals of Japanese ancestry with genotype imputation with genotypes imputation detected eight new susceptibility loci and Japanese-specific rare variants contributing to disease severity and increased cardiovascular mortality, and a trans-ancestry meta-analysis found 35 additional new loci.
Journal ArticleDOI

Promotion of CHIP-Mediated p53 Degradation Protects the Heart From Ischemic Injury

TL;DR: In this paper, the authors investigated the molecular mechanisms of p53 accumulation in the heart after myocardial infarction and tested whether anti-p53 approach would be effective against myocardious infarctions.